RWD study: Lenvima shows high efficacy in thyroid cancer
Eisai recently announced the final results of a real-world data (RWD) study at the 91st American Thyroid Association (ATA) Annual Meeting in 2022. This study
Eisai recently announced the final results of a real-world data (RWD) study at the 91st American Thyroid Association (ATA) Annual Meeting in 2022. This study
There is no accident, let alone fluke, in the research and development of innovative drugs. Even if a star product has proven itself in many